Clinical Trial Update: Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care [Phase 2]

View source ↗

Summary

A Phase 2 study by Bristol-Myers Squibb evaluating an antiviral combination therapy for chronic hepatitis C in patients who had not received the standard of car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Antiviral Combination Therapy

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2015-10-23